Abreu-BTT Continuous System for hospital use of continuous temperature monitoring
Our devices are not yet available for sale in the U.S.
Today, the only method in use in the OR/ICU for continuous temperature monitoring is the oesophageal or Foley catheter. There are 15 million central venous catheter days that occur in ICUs each year. But catheters are invasive and uncomfortable. Moreover, catheters can become colonized by organisms and cause infection, sepsis and death.
In the OR/ICU, BTT™ devices are expected to quickly displace their outdated counterparts resulting in greatly increased patient comfort, safety and care. This will have the added benefit of reducing Foley catheter costs.
According to the Centers For Disease Control (CDC),
an estimated 250,000 catheter-related bloodstream infections (CRBSIs) occur in U.S. hospitals each year.
An estimated 28,000 of these patients die annually.
References: Digital Journal, Healthcare 411
The estimated annual cost of caring for patients with CRBSIs ranges from $296 million
to $2.3 billion. There are two million hospital infection cases each year -- and 99,000 patients die of them as a result -- according to the CDC.
- Risk: Noninvasive, no infection or medical complication
- Accuracy: Direct temperature measurement at the surface of the skin for accurate diagnosis & treatment
- Cost: Eliminate unnecessary hospital tests, reduce nursing labor cost and hospitalization time
- Patient Care: Prevent surgical and neurological complication, reduce patient pain and suffering
- Technology: Continuous and neo-continuous monitoring, recording, alert, web access, system integration, wired or wireless